HPCAL1 and cholangiocarcinoma: This finding suggests that the higher the HPCAL1 expression in CCA patients, the greater the CA‐125 level (p = 0.04), number of tumors (p = 0.04), lymph node invasion (p = 0.02), and TNM stage (p = 0.04).